IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14

Reporting Person: Lane Michael (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-14	Common Stock	M	221	—	Acquired	4005	Direct
2021-02-14	Common Stock	M	212	—	Acquired	4217	Direct
2021-02-14	Common Stock	M	196	—	Acquired	4413	Direct
2021-02-14	Common Stock	M	181	—	Acquired	4594	Direct
2021-02-14	Common Stock	M	174	—	Acquired	4768	Direct
2021-02-14	Common Stock	F	314	$544.08	Disposed	4474	Direct
2021-02-16	Common Stock	S	850	$545	Disposed	3624	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-14	Non-Qualified Stock Option (right-to-buy)	$544.08	A	6003	Acquired	2031-02-13	Common Stock (6003)	Direct
2021-02-14	Incentive Stock Option (right-to-buy)	$544.08	A	183	Acquired	2031-02-13	Common Stock (183)	Direct
2021-02-14	Restricted Stock Unit	$	A	643	Acquired		Common Stock (643)	Direct
2021-02-14	Restricted Stock Unit	$	M	221	Disposed		Common Stock (221)	Direct
2021-02-14	Restricted Stock Unit	$	M	212	Disposed		Common Stock (212)	Direct
2021-02-14	Restricted Stock Unit	$	M	196	Disposed		Common Stock (196)	Direct
2021-02-14	Restricted Stock Unit	$	M	181	Disposed		Common Stock (181)	Direct
2021-02-14	Restricted Stock Unit	$	M	174	Disposed		Common Stock (174)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	592	Indirect

Footnotes

F1: Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.

F2: Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.

F3: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.

F5: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.

F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F11: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F12: Not applicable.